CCT5 as a candidate biomarker in bladder cancer: functional validation and mechanistic clues. [PDF]
Zhang X +8 more
europepmc +1 more source
Multi-omics characterization identifies AHCY as a prognostic biomarker driving immunometabolic reprogramming in bladder cancer. [PDF]
Peng Q +8 more
europepmc +1 more source
USP43 promotes gemcitabine resistance by regulating cholesterol homeostasis through E2F1 stabilization in bladder cancer. [PDF]
Li M +14 more
europepmc +1 more source
Uncovering the prognostic implications and immunological roles of transmembrane protein 208 in bladder cancer by multi omics analysis and experimental verification. [PDF]
Mao Q +9 more
europepmc +1 more source
Characteristics of The Cancer Genome Atlas cases relative to U.S. general population cancer cases [PDF]
Bailey, Matthew H +5 more
core +1 more source
Retraction: Mechanistic Analysis of the Role of BLCA-4 in Bladder Cancer Pathobiology [PDF]
openaire +1 more source
The expression of mercaptopyruvate sulfurtransferase serves as a potential biomarker for prognostic stratification and immunotherapy in certain cancers. [PDF]
Cui B +9 more
europepmc +1 more source
Progressively exploring and assessing the prognosis of bladder urothelial cancer based on the microenvironment through the integration of multiple databases. [PDF]
Zou X, Li Y, Peng X, Gu C, Wang Q.
europepmc +1 more source
V2V communications for vehicle safety applications in blind road spots: the highway and urban scenario [PDF]
Σπυρόπουλος, Χρήστος Α.
core
Targeting PSMB5-induced PANoptosis in bladder cancer: multi-omics insights and TCM candidate discovery. [PDF]
Chang Z +10 more
europepmc +1 more source

